Abstract
Understanding the expanding role played by tumor markers in screening for cancer, assessing risk, and monitoring for disease recurrence is essential for their appropriate use. New markers, such as HER2, herald new tumor-specific therapeutic strategies.
Original language | English (US) |
---|---|
Pages (from-to) | 109-124 |
Number of pages | 16 |
Journal | Patient Care |
Volume | 33 |
Issue number | 6 |
State | Published - Mar 30 1999 |
ASJC Scopus subject areas
- Leadership and Management